We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$484B
$343M 9.78%
1,075,000
+46,800
+5% +$15M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$337M 9.6%
850,000
+145,000
+21% +$55.9M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$83B
$308M 8.77%
1,392,500
+406,500
+41% +$88.8M
XBI icon
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$224M 6.38%
1,650,000
+480,900
+41% +$72M
XLV icon
5
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$117M 3.33%
1,000,000
+550,000
+122% +$63.5M
ARKK icon
6
PUT
ARK Innovation ETF
ARKK
$6.31B
$74.7M 2.13%
+622,500
New +$84.2M
ESTA icon
7
Establishment Labs
ESTA
$2.28B
$68.8M 1.96%
1,100,834
-81,612
-7% -$4.71M
NSTG
8
DELISTED
NanoString Technologies, Inc.
NSTG
$66.3M 1.89%
1,009,027
-6,337
-0.6% -$445K
IMDX
9
Insight Molecular Diagnostics
IMDX
$156M
$63.4M 1.81%
611,198
+297,057
+95% +$28.2M
ARKG icon
10
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
$62.1M 1.77%
700,000
+385,000
+122% +$38.2M
IBB icon
11
PUT
iShares Biotechnology ETF
IBB
$9.77B
$52.7M 1.5%
350,000
+127,500
+57% +$20.3M
INOV
12
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$47.4M 1.35%
1,648,358
+218,974
+15% +$5.63M
MCK icon
13
PUT
McKesson
MCK
$101B
$43.9M 1.25%
+225,000
New +$41.1M
FXH icon
14
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
$43.7M 1.24%
402,000
+212,000
+112% +$23.2M
INSP icon
15
Inspire Medical Systems
INSP
$1.74B
$42.3M 1.2%
204,187
+13,645
+7% +$2.9M
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
$41.9M 1.19%
9,632,701
+1,837,114
+24% +$8.92M
ATRC icon
17
AtriCure
ATRC
$2.11B
$40.4M 1.15%
615,950
-99,699
-14% -$6.14M
CI icon
18
PUT
Cigna
CI
$74.6B
$38.7M 1.1%
160,000
+60,000
+60% +$13.4M
PPH icon
19
PUT
VanEck Pharmaceutical ETF
PPH
$938M
$38M 1.08%
550,000
+350,000
+175% +$24.1M
MDVL
20
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$31.6M 0.9%
46,844
-4,916
-9% -$3.53M
ICUI icon
21
ICU Medical
ICUI
$4.61B
$30.5M 0.87%
148,548
-25,851
-15% -$5.46M
STAA icon
22
STAAR Surgical
STAA
$1.21B
$30.3M 0.86%
287,238
-70,818
-20% -$7.09M
UNH icon
23
PUT
UnitedHealth
UNH
$370B
$27.9M 0.8%
75,000
-35,000
-32% -$12.1M
ORGO icon
24
Organogenesis Holdings
ORGO
$239M
$27.5M 0.78%
1,507,552
-300,002
-17% -$4.06M
HYFM icon
25
Hydrofarm Holdings
HYFM
$7.62M
$27M 0.77%
44,832
+7,332
+20% +$5.15M
1
2 3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.